Literature DB >> 15811132

Tumor-host interactions contribute to the elevated expression level of alpha1-antichymotrypsin in metastatic breast tumor xenografts.

Valerie Montel1, Kersi Pestonjamasp, Evangeline Mose, David Tarin.   

Abstract

We investigated alpha1-antichymotrypsin (ACT) gene expression in xenograft tumors generated by two isogenic human breast cancer cell lines derived from the same parent, MDA-MB-435, which display opposite metastatic behaviors. Microarray and real-time PCR experiments showed an overexpression of this serine protease inhibitor in the metastatic tumors (M-4A4T) and its derived metastases (M4-Mets) compared with the weakly metastatic tumors (NM-2C5T), and its release into the blood was confirmed by western-blotting. However, functional assays in vivo using genetically engineered tumor cells demonstrated that ACT up-regulation was not, by itself, responsible for the metastatic phenotype. We also made observations that ACT gene regulation was sensitive to tumor-host interactions: inoculation of these lines into the mouse mammary gland greatly increased ACT production and accentuated the intrinsic difference observed when they are cultured in vitro. Sensitivity of tumor cells to their environment was further analyzed by in vitro experiments, which demonstrated that a purified ECM environment and soluble components from normal host mammary cells were both able to significantly promote ACT expression. In addition, we took advantage of the xenogeneic nature of the model to measure ACT expression by the host cells (mouse) and the tumor cells (human) within the neoplasm using species-specific primers in real-time PCR experiments. It was found that the presence of tumor cells, irrespective of their metastatic capabilities, induced local ACT production by host cells at the primary and secondary tumor sites. Thus, this work indicates that there is a specific association of ACT overexpression with the metastatic phenotype in our breast cancer metastasis model. Moreover, because of the xenogeneic nature of our system, we were able to provide evidence of tumor-host reciprocal regulation of ACT production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811132     DOI: 10.1111/j.1432-0436.2005.07302001.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  5 in total

1.  Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303).

Authors:  Andrew S Roberts; Michael J Campa; Elizabeth B Gottlin; Chen Jiang; Kouros Owzar; Hedy L Kindler; Alan P Venook; Richard M Goldberg; Eileen M O'Reilly; Edward F Patz
Journal:  Cancer       Date:  2011-06-28       Impact factor: 6.860

2.  Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications.

Authors:  Mika Suzuki; David Tarin
Journal:  Mol Oncol       Date:  2007-04-07       Impact factor: 6.603

3.  Osteopontin gene expression determines spontaneous metastatic performance of orthotopic human breast cancer xenografts.

Authors:  Mika Suzuki; Evangeline Mose; Christine Galloy; David Tarin
Journal:  Am J Pathol       Date:  2007-07-09       Impact factor: 4.307

4.  Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients.

Authors:  Dingyuan Luo; Wei Chen; Yun Tian; Junliang Li; Xinke Xu; Cheng Chen; Fangcheng Li
Journal:  Onco Targets Ther       Date:  2017-04-18       Impact factor: 4.147

5.  Up-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cells.

Authors:  Jiaying Zhou; Yabin Cheng; Liren Tang; Magdalena Martinka; Sunil Kalia
Journal:  Oncotarget       Date:  2017-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.